Intriguingly, the expression of SHMT1, MTHFD1, and ALDH1L1 had no influence on the survival rate of patients with CRC and LA (Supplementary Figure 1), suggesting it is not the folate metabolism per se but the THF cycle in the mitochondria that confers poor prognosis in cancers. The gene discussed is ALDH1L1; the disease is cancer.